Project Grant 2426759

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $200K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Silver Spring, MD 20993, USA
Similar Awards
This National Science Foundation (NSF) Engineering (CFDA 47.041) program grant, in the amount of $400,000, supports the development of a tissue-like, converged sensing platform for tracking excitation-contraction dynamics in cardiac organoids. The project aims to: Develop a scalable assembly strategy to fabricate an array of three-dimensional sensor structures using planar semiconducting graphene material, designed to detect both electrical and mechanical stimuli. Evaluate the multifunctional...
This $100,000 Project Grant from the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems supports the development of a 3D human stem cell cardiac model for cardiac electrophysiology medical device safety assessment. Funded under the NSF Engineering program (CFDA 47.041), this award will allow the University of Maryland, College Park to create a novel in vitro model for evaluating the safety and efficacy of cardiac medical devices through January...
This $599,486 National Science Foundation award under the Engineering (47.041) program will fund the development of an engineered cardiac tissue model with embedded soft microelectronics for continuous cardiotoxicity screening at The Pennsylvania State University from January 2022 to September 2023. The key product is a 3D-bioprinted, microvascularized cardiac tissue model integrated with stretchable microelectronics to enable real-time, intra-tissue measurement of cardiotoxicity responses to...
The National Science Foundation awarded a $450,000 Project Grant to the George Washington University under the Engineering federal grant program (CFDA 47.041) to develop scalable heart-on-a-chip platforms. Over a three-year period from April 2022 through March 2025, the University will create automated systems integrating human heart slice culture components with sensor and actuator arrays. This will enable continuous on-chip multiparametric analysis of human cardiac physiology at the cellular...
The National Science Foundation (NSF) Engineering program (CFDA 47.041) has awarded a $467,202 project grant to the Research Foundation of the City University of New York (RFCUNY) to develop an intelligent lab-on-chip device that can non-invasively monitor the maturation of stem cell-derived cardiomyocytes in real-time and apply adaptive biophysical stimulation to promote full cell maturation. The interdisciplinary research team from RFCUNY, City College of New York, and Rutgers University plans...
This Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) is supporting a collaborative research effort focused on developing an intelligent lab-on-chip device to monitor and promote the maturation of stem cell-derived cardiomyocytes. The $192,150 award to the New York Institute of Technology (NYIT) aims to create an integrated system that can non-invasively evaluate cardiomyocyte maturity in real-time and adaptively apply electrical and mechanical...
This Project Grant award, provided by the National Science Foundation's Engineering program (CFDA 47.041), aims to develop and optimize a communication platform for networking multiple wearable and implantable bioelectronic devices throughout the human body. The $499,896 award, granted to Georgia Tech Research Corp on June 15, 2025, will support the scientific goal of optimizing an emitter and receiver network between electromechanical wearable sensors and implantable actuators. This project...
This National Science Foundation (NSF) Faculty Early Career Development (CAREER) Program award, funded under CFDA 47.041 Engineering, aims to enhance the understanding of mechanisms driving cardiac arrhythmias. The $418,901 project, awarded on February 1, 2025, with a completion date of January 31, 2030, integrates complex computational simulations of electrical, mechanical, and fluid dynamics with advanced deep-learning techniques. This holistic research pathway will uncover how multiple...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to develop a flexible bioelectronic microarchitecture that integrates a capillary-like delivery network and a tissue-like sensing network to improve cardiac tissue engineering. The $488,026 award supports the creation of a system that can efficiently deliver media and provide real-time physiological feedback to enhance the development of...
This $500,000 Project Grant award, provided by the National Science Foundation's Engineering program (CFDA 47.041), supports the development and validation of automated optoelectronic lab-on-a-chip platforms for comprehensive, real-time, multiparametric monitoring and control of live cell physiology. The research objectives include: 1) Exploring cellular-scale components for crosstalk-free electrical recording, stimulation, and fluorescence monitoring of in vitro live cell function; 2)...

This Project Grant award from the National Science Foundation (NSF) under the Engineering program (CFDA 47.041) provides $199,992 to Boston University to develop a high-throughput electrical stimulation screening platform for assessing the long-term effects of cardiac contractility modulation (CCM) devices on engineered human heart tissue. The project will support a postdoctoral scholar co-mentored by researchers at the Food and Drug Administration (FDA) and Boston University to advance regulatory science tools for evaluating the safety and effectiveness of medical devices that use electrical stimulation to treat heart disease. The research aims to create an in vitro system that can be used to assess the chronic impacts of non-excitatory electrical stimulations on cardiac electrophysiology, which will help regulatory agencies better understand the effects of emerging heart treatment technologies. The award runs from September 1, 2024, to August 31, 2026.

Generated 5/13/25, 2:49 AM